Carlota Rubio-Perez - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Carlota Rubio-Perez's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Carlota Rubio-Perez
Verified
Science Contributor, Clinical Cancer Research
Beats
Psychology, Medicines, Clinical Trials, Mindfulness Immune System, Suffering, Religion,Covid19 Meditation, Lymphoma, Christianity, Leukemia Health, Philosophy, Psychiatry, Theology Blood Cancer
Interested in just about anything...
Content
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
By Laura Escudero, Anna Llort, Ander Díaz-Navarro, Carlota Rubio-Perez| Nature Verified AbstractThe molecular characterisation of medulloblastoma, the most common paediatric brain tumour, is crucial for the correct management and treatment of this heterogenous disease. However, insufficient tissue sample, the presence of tumour heterogeneity, or disseminated disease can challenge its diagnosis and monitoring.
A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations
By David Tamborero, Carlota Rubio-Perez, Ferran Muiños, Biomedical Genomics| AACR Journal@ A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations David Tamborero, Carlota Rubio-Perez, Ferran Muiños, Radhakrishnan Sabarinathan, Josep Maria Piulats, Aura Muntasell, Rodrigo Dienstmann, Nuria Lopez-Bigas and Abel Gonzalez-Perez Clin Cancer Res April 17 2018 DOI: 10.1158/1078-0432.CCR-17-3509
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
By Laura Escudero, Anna Llort, Ander Díaz-Navarro, Carlota Rubio-Perez| Nature Verified AbstractThe molecular characterisation of medulloblastoma, the most common paediatric brain tumour, is crucial for the correct management and treatment of this heterogenous disease. However, insufficient tissue sample, the presence of tumour heterogeneity, or disseminated disease can challenge its diagnosis and monitoring.
Company Info
Clinical Cancer Research
Barcelona, Catalonia, Spain
+34 934 02 02 50